Enzyme therapy for Pompe disease: from science to industrial enterprise

[1]  J. Hobbs.  Bone marrow transplants in genetic diseases , 2005, European Journal of Pediatrics.

[2]  A. Reuser,et al.  Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells , 1988, Journal of Neurology.

[3]  S. Brodie,et al.  A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. , 2001, American journal of human genetics.

[4]  J. Belmont,et al.  Enzyme-replacement therapy in mucopolysaccharidosis I. , 2001, The New England journal of medicine.

[5]  J. Charrow,et al.  Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.

[6]  R. Schiffmann,et al.  Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Reuser,et al.  Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. , 2000, Lancet.

[8]  P. Visser,et al.  Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. , 1999, Human molecular genetics.

[9]  A. Reuser,et al.  Recombinant Human Acid α-Glucosidase: High Level Production in Mouse Milk, Biochemical Characteristics, Correction of Enzyme Deficiency in GSDII KO Mice , 1998 .

[10]  N. Leslie,et al.  Enzyme therapy for Gaucher disease: the first 5 years. , 1998, Blood reviews.

[11]  J. V. Van Hove,et al.  Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail. , 1998, The Journal of clinical investigation.

[12]  R. Brady,et al.  High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Mancini,et al.  Chapter 5 Lysosomal storage diseases , 1996 .

[14]  A. Reuser,et al.  Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice. , 1996, Biochimica et biophysica acta.

[15]  A. Reuser,et al.  Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐Glucosidase , 1995 .

[16]  A. Reuser,et al.  Glycogenosis type II (acid maltase deficiency) , 1995, Muscle & nerve. Supplement.

[17]  L. Houdebine.  Production of pharmaceutical proteins by transgenic animals , 2008, Comparative Immunology, Microbiology and Infectious Diseases.

[18]  J. Dambrosia,et al.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. , 1991, The New England journal of medicine.

[19]  F. Martiniuk,et al.  Isolation and partial characterization of the structural gene for human acid alpha glucosidase. , 1991, DNA and cell biology.

[20]  A. Reuser,et al.  Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice. , 1991, The Journal of clinical investigation.

[21]  L. Hoefsloot,et al.  Characterization of the human lysosomal alpha-glucosidase gene. , 1990, The Biochemical journal.

[22]  F. Martiniuk,et al.  Sequence of the cDNA and 5'-flanking region for human acid alpha-glucosidase, detection of an intron in the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. , 1990, DNA and cell biology.

[23]  R. Brady,et al.  Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Galjaard,et al.  Receptor-Mediated Uptake of Acid α-Glucosidase Corrects Lysosomal Glycogen Storage in Cultured Skeletal Muscle , 1988, Pediatric Research.

[25]  L. Hoefsloot,et al.  Primary structure and processing of lysosomal alpha‐glucosidase; homology with the intestinal sucrase‐isomaltase complex. , 1988, The EMBO journal.

[26]  W. J. Visser,et al.  Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid α-glucosidase , 1987, Journal of the Neurological Sciences.

[27]  W. J. Visser,et al.  Uptake and stability of human and bovine acid alpha-glucosidase in cultured fibroblasts and skeletal muscle cells from glycogenosis type II patients. , 1984, Experimental cell research.

[28]  J. Tager,et al.  An appraisal of human trials in enzyme replacement therapy of genetic diseases. , 1980, Birth defects original article series.

[29]  W. Sly,et al.  Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Morell,et al.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. , 2006, Advances in enzymology and related areas of molecular biology.

[31]  E. Neufeld,et al.  A recognition marker required for uptake of a lysosomal enzyme by cultured fibroblasts. , 1974, Biochemical and biophysical research communications.

[32]  W. Schubert,et al.  LYSOSOMES IN TYPE II GLYCOGENOSIS , 1967, The Journal of cell biology.

[33]  C. Duve,et al.  Functions of lysosomes. , 1966, Annual review of physiology.

[34]  P. Baudhuin,et al.  AN ELECTRON MICROSCOPIC AND BIOCHEMICAL STUDY OF TYPE II GLYCOGENOSIS. , 1964, Laboratory investigation; a journal of technical methods and pathology.

[35]  H. Hers.  α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease) , 1963 .